Germline-encoded pattern recognition receptors (PRRs) mediate an early innate immune response against viral pathogens.
Retinoic acid-inducible gene I protein (RIG-I) and melanoma differentiation-associated protein 5 (MDA5) are cytoplasmic sensors that detect viral RNA species and signal through the mitochondrial antiviral-signalling protein (MAVS) to induce the production of type I interferons (IFNs) and other cytokines.
Intracellular DNA sensors, such as cyclic GMP–AMP synthase (cGAS) and IFNγ-inducible protein 16 (IFI16), detect viral DNA in the cytoplasm and/or nucleus and signal through the stimulator of IFN genes (STING) to trigger an immune response.
Viruses antagonize PRRs through the sequestration or modification of their viral genomes and through the manipulation of post-translational modifications of PRRs or their adaptor proteins. Some viruses cleave or degrade PRRs or their adaptors, or sequester and relocalize PRRs to escape immunity.
A better understanding of the cellular immune-surveillance machinery and viral immune evasion strategies may guide the development of antiviral therapeutics and vaccines.
Pattern recognition receptors (PRRs) detect conserved molecular features of viral pathogens and initiate signalling that results in the expression of antiviral genes. In this Review, Chan and Gack highlight the major classes of intracellular viral RNA and DNA sensors and discuss the viral strategies that are used to escape immune surveillance by those sensors.
The co-evolution of viruses with their hosts has led to the emergence of viral pathogens that are adept at evading or actively suppressing host immunity. Pattern recognition receptors (PRRs) are key components of antiviral immunity that detect conserved molecular features of viral pathogens and initiate signalling that results in the expression of antiviral genes. In this Review, we discuss the strategies that viruses use to escape immune surveillance by key intracellular sensors of viral RNA or DNA, with a focus on RIG-I-like receptors (RLRs), cyclic GMP–AMP synthase (cGAS) and interferon-γ (IFNγ)-inducible protein 16 (IFI16). Such viral strategies include the sequestration or modification of viral nucleic acids, interference with specific post-translational modifications of PRRs or their adaptor proteins, the degradation or cleavage of PRRs or their adaptors, and the sequestration or relocalization of PRRs. An understanding of viral immune-evasion mechanisms at the molecular level may guide the development of vaccines and antivirals.